Nonclinical Toxicology and Biocompatibility Program Supporting Clinical Development and Registration of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration
Year: 2020
Type: article
Source: Toxicologic Pathology
Authors: Vladimir Bantseev, Joshua Horvath, Giulio Barteselli, Shrirang Ranade, Mauricio Maia, Daniela Bumbaca Yadav, Chris Schuetz, Amy Shelton, Helen S. Booler
Institution: Genentech
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Genentech
OpenAlex ID: W3099337736
